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Although  neuroimmune  interactions  associated  with  the  development  of  pain  sensitization  in  models  of
neuropathic  pain  have  been  widely  studied,  there  are  some  aspects  that  require  further  investigation.
Thus,  we  aimed  to evaluate  whether  the  local  intraneural  or  perineural  injections  of  dexamethasone,  an
efﬁcacious  anti-inﬂammatory  and  immunosuppressant  drug,  delays  the  development  of both  thermal
hyperalgesia  and  mechanical  allodynia  in  an experimental  model  of  neuropathic  pain  in  rats.  Hargreaves
and  electronic  von  Frey  tests  were  applied.  The  chronic  constriction  injury  (CCI)  of right  sciatic  nerve  was
performed.  Single  intraneural  dexamethasone  administration  at  the  moment  of constriction  delayed  theeripheral  neuropathy
nﬂammation
euroimmune interaction
orticosteroid
development  of  sensitization  for  thermal  hyperalgesia  and  mechanical  allodynia.  However,  perineural
administration  of  dexamethasone,  at the  highest  dose,  did not  delay  experimental  pain  development.
These  results  show  that  inﬂammation/immune  response  at the  site  of  nerve  lesion  is  an  essential  trigger
for  the pathological  changes  that lead  to both  hyperalgesia  and  allodynia.  In conclusion,  this  approach
opens  new  opportunities  to  study  cellular  and  molecular  neuroimmune  interactions  associated  with  the
development  of  pain  derived  from  peripheral  neuropathies.. Introduction
Immune activation and the subsequent release of immune
ediators in the peripheral nervous system contribute to pain.
 variety of peripheral immune cells, including mast cells,
acrophages, and lymphocytes, are resident in peripheral nerves
nd/or recruited to sites of peripheral nerve injury [23,24]. These
ells produce a plethora of inﬂammatory mediators that sensitize
r directly activate peripheral nerves to generate action potentials,
eading to peripheral and central sensitization [4].
Additional support to a role played by neuroinﬂammation in
he development of experimental pain arises from the ﬁnding that
examethasone, a potent anti-inﬂammatory and immunosuppres-
ant drug, inhibits ﬁbrovascular tissue formation around sutures,
nﬁltration of inﬂammatory cells and thermal hyperalgesia when
Abbreviations: CCI, chronic constriction injury; CGRP, calcitonin gene-related
eptide;  DRG, dorsal root ganglion.
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administered intraperitoneally before and after CCI in rats [3]. It
is tempting to associate the antihyperalgesic effect induced by
dexamethasone to its action at the site of the nerve injury, lead-
ing to reduced inﬁltration of inﬂammatory cells and production
of inﬂammatory mediators. However, when glucocorticoids are
administered systemically, the site(s) of their action is(are) not
clear as it has been shown that these drugs may  also induce exper-
imental pain suppressive effects after intrathecal administration in
experimental models of neuropathic pain [12,25]. However, when
rats are subjected to CCI and have the sciatic nerves re-exposed
and treated locally with a depot form of methylprednisolone at
day 10 after injury, antiallodynic and antihyperalgesic effects are
observed up to day 21 [9], thus providing evidence that gluco-
corticoids may  act locally at the site of nerve injury to inhibit
sensitization. These results indicate that glucocorticoids applied
around the site of nerve injury may  reverse the sensitization when
this phenomenon is fully established. To further elucidate the site
of action of glucocorticoids, in the present study we investigated
Open access under the Elsevier OA license.the ability of intraneural versus perineural administration of dex-
amethasone to prevent the development of thermal hyperalgesia
and mechanical allodynia, when the drug was delivered at the time
of sciatic injury in rats.
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Fig. 1. Effect induced by chronic constriction injury (CCI) on the development of
thermal hyperalgesia (A) and mechanical allodynia (B) in rats. Data are expressed as
mean ± standard error of the mean (n = 5–7). *p < 0.05 compared with the vehicle-
treated group at the respective time-point, tested by two-way repeated measuresL.F.S. Bastos et al. / Neuros
. Materials and methods
.1.  Animals
All  experiments were performed according to the ethical guide-
ines for the investigation of experimental pain in conscious
nimals [28] and approved by the Ethics Committee on Animal
xperimentation of the Federal University of Minas Gerais (proto-
ol # 168/10). Male Wistar rats (240–280 g) were used, with groups
atched on body mass (approximately 260 g). Efforts were made
o minimize both animal distress and the number of animals used.
he animals had free access to food and water and were main-
ained in a room with a 12 h light–dark cycle for 3 days before
he experiment to allow for acclimatization. The experiments were
onducted in the middle of light circadian phase, at room tempera-
ure between 26 and 28 ◦C, which corresponds to the thermoneutral
one for rats [7]. For three consecutive days before the experi-
ent, the animals were habituated for approximately 30 min  to
he experimental apparatuses in order to minimize stress-induced
ntinociception. The investigator performing behavioral tests was
lind to treatments.
.2.  Surgery and drug administration
CCI  of the right sciatic nerve was performed as previously
escribed by Bennett and Xie [2], under anesthesia induced by
etamine (90 mg/kg) and xylazine (9 mg/kg) hydrochlorides (both
anufactured by Vetbrands; Paulínia, São Paulo, Brazil). Four lig-
tures with a ﬂexible nylon thread (Saniﬁll, Rio de Janeiro, Brazil)
ere tied loosely around the sciatic nerve at mid-thigh level [13].
ham-operated animals underwent the same surgical procedure,
ave that the sciatic was not ligated. When dexamethasone (100
r 250 g/kg assuming 260 g rat on average hence 26 or 65 g/rat;
igma–Aldrich, St. Louis, MO,  USA) or equivolume (10 l) saline
ehicle was injected directly into the sciatic nerve or adminis-
ered perineurally onto the nerve, the two outermost ligatures were
laced ﬁrst and injection was performed using a 30-gage needle
onnected to a Hamilton syringe (Reno, NV, USA) in the center
etween the ligatures. Then, the remaining middle two sutures
ere placed, as previously described [21].
.3. Evaluation of thermal hyperalgesia
Paw withdrawal latency to a thermal stimulus was measured
ith a plantar test unit (model 7370, Ugo Basile, Comerio, Italy).
rieﬂy, rats were kept in Perspex cells having a glass pane as a
oor and a source of infrared light was directed upwards from
elow the glass toward the right hind paw plantar surface [8]. Cut-
ff time (20 s) was imposed to avoid tissue damage. The value for
he response was obtained by averaging three measurements, with
ach determination separated by a minimum of 20 s. These pro-
edures were performed under the same laboratory conditions as
reviously described [16].
.4.  Evaluation of mechanical allodynia
Rats were placed in acrylic cages with wire mesh ﬂoors 15 min
efore the start of testing. The test consisted of evoking a hind
aw ﬂexion reﬂex with a hand-held force transducer (electronic
ressure-meter, Insight, Ribeirão Preto, Brazil) adapted to a 0.5-
m2 polypropylene tip. The experimenter was trained to apply
he tip perpendicularly to the central area of the hind paw
ith a gradual increase in pressure. The endpoint was charac-
erized by the removal of the paw usually followed by ﬂinching
ovements. After the paw withdrawal, the intensity of the pres-
ure was automatically recorded. The value for the responseANOVA  followed by Bonferroni post hoc test, taking time and surgery as main factors.
Naive and sham-operated animals were unaffected by the surgery factor at all time
points.
was  obtained by averaging ﬁve measurements. The animals were
tested before and after surgeries and/or treatments. The results
are expressed by the absolute withdrawal threshold (in grams).
These procedures were similar to those previously described
[20].
2.5. Statistical analyses
The  results, expressed as mean ± standard error of the mean,
were analyzed by two-way repeated measures ANOVA followed by
Bonferroni post hoc test, taking surgery and time (Fig. 1A and B) or
treatment and time (Figs. 2A, B and 3A, B) as main effects. Values
of p < 0.05 were considered to show signiﬁcant differences between
means. The software GraphPad Prism® 5.0 (San Diego, CA, USA) was
used for the analyses.
3.  Results
Thermal hyperalgesia was observed from day 3 after surgery
onward (Fig. 1A; main effect of surgery factor: F(2,100) = 21.68,
p < 0.0001; main effect of time: F(5,100) = 2.64, p = 0.0275; interac-
tion: F(10,100) = 1.87, p = 0.0588), whereas mechanical allodynia was
observed from day 7 onward (Fig. 1B; main effect of surgery fac-
tor: F(2,240) = 10.66, p = 0.0011; main effect of time: F(15,240) = 3.95,
p < 0.0001; interaction: F(30,240) = 3.01, p < 0.0001).
Next, it was  tested whether a single intraneural injection of
dexamethasone at the time of sciatic injury could delay the devel-
opment of both thermal hyperalgesia and mechanical allodynia. We
22 L.F.S.  Bastos et al. / Neuroscience Letters 510 (2012) 20– 23
Fig. 2. Intraneural dexamethasone (dexa; 100 or 250 g/kg, 10 l) at the moment of
chronic constriction injury (CCI) delayed the development of thermal hyperalgesia
(A)  and mechanical allodynia (B) in rats. Data are expressed as mean ± standard error
of the mean (n = 5–8). *p < 0.05 and **p < 0.01 compared with the vehicle-treated
group  at the respective time-point, tested by repeated measures two-way ANOVA
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Fig. 3. Perineural dexamethasone (dexa; 250 g/kg, 10 l) at the moment of chronic
constriction  injury (CCI) did not delay the development of thermal hyperalge-
sia  (A) and mechanical allodynia (B) in rats (p > 0.05). Data are expressed as
mean  ± standard error of the mean (n = 7–8) and tested by repeated measures two-ollowed by Bonferroni post hoc test, taking time and treatment as main factors.
ham-operated  animals were unaffected by treatment at all time points.
bserved that intraneural treatment with the highest (250 g/kg)
ose of dexamethasone led to a rightward shift in the curve of sensi-
ization for thermal (Fig. 2A; main effect of treatment: F(2,68) = 5.13,
 = 0.0181; main effect of time: F(4,68) = 21.08, p < 0.0001; inter-
ction: F(8,68) = 0.88, p = 0.5346) and mechanical (Fig. 2B; main
ffect of treatment: F(1,52) = 4.82, p = 0.0468; main effect of time:
(4,52) = 18.94, p < 0.0001; interaction: F(4,52) = 3.01, p = 0.0261) stim-
li. Sham-operated animals had their thermal (Fig. 2A; main
ffect of treatment: F(1,56) = 0.47, p = 0.5060; main effect of time:
(4,56) = 4.97, p = 0.0017; interaction: F(4,56) = 0.50, p = 0.7371) and
echanical (Fig. 2B; main effect of treatment: F(1,56) = 0.48,
 = 0.4977; main effect of time: F(4,56) = 1.75, p = 0.1528; interaction:
(4,56) = 0.95, p = 0.4398) sensitivities unaffected by treatment over
he time course evaluated (Fig. 2A and B).
Finally, when the administration of dexamethasone (250 g/kg)
as performed perineurally, neither antihyperalgesic (main effect
f treatment: F(1,22) = 1.28, p = 0.2814; main effect of time:
(2,22) = 17.91, p < 0.0001; interaction: F(2,22) = 0.31, p = 0.7342) nor
ntiallodynic (main effect of treatment: F(1,22) = 0.01, p = 0.9415;
ain effect of time: F(2,22) = 78.72, p < 0.0001; interaction:
(2,22) = 0.27, p = 0.7628) effects were observed in CCI rats (Fig. 3).
ikewise, both thermal (main effect of treatment: F(1,24) = 0.10,
 = 0.7626; main effect of time: F(2,24) = 0.06, p = 0.9446; interaction:
(2,24) = 0.49, p = 0.6213) and mechanical (main effect of treat-
ent: F(1,24) = 0.52, p = 0.4866; main effect of time: F(2,24) = 2.16,
 = 0.1374; interaction: F(2,24) = 2.28, p = 0.1237) sensitivities of
ham-operated rats were unaffected by treatment over the time
ourse evaluated (Fig. 3).way ANOVA followed by Bonferroni post hoc test, taking time and treatment as main
factors. Sham animals were also unaffected by treatment at all time-points (p > 0.05).
4. Discussion and conclusions
In the present study, we show that the intraneural, but not
perineural, administration of dexamethasone (250 g/kg based on
260 g rats, on average) delays the development of both thermal
hyperalgesia and mechanical allodynia in CCI rats when admin-
istered at the time of sciatic nerve injury. While not examined
here, we predict that intraneural dexamethasone, but not per-
ineural dexamethasone, inhibited the inﬁltration of inﬂammatory
cells into the nerve and may  have also inhibited the production
of inﬂammatory mediators by Schwann cells. Suppression of neu-
ropathic pain development by intraneural dexamethasone cannot
be accounted for by systemic spread, given that perineural dex-
amethasone would more readily become systemic, yet perineural
dexamethasone failed to affect the development of neuropathic
pain. Furthermore, the fact that different time courses were
observed for intraneural dexamethasone effects on hyperalgesia
and allodynia reinforces prior evidence that CCI-induced thermal
hyperalgesia and mechanical allodynia have distinct underlying
mechanisms [4].
It  has previously been shown that dexamethasone has a 2.3 h
half-life after either intravenous or intramuscular injection in rats
[18]. However, no information is available about the pharmacoki-
netics of this drug after intraneural administration. If one assumes
that dexamethasone exhibits similar pharmacokinetics after sys-
temic versus intraneural administration, it would then be highly
likely that dexamethasone had already been biotransformed and
eliminated by the time that antiallodynic effects were observed.
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f this is true, then these results support that a short-lasting anti-
nﬂammatory, immunosuppressant treatment, administered at the
ime of nerve injury, can be sufﬁcient to delay experimental pain
evelopment for days. Consistent with our ﬁndings, local adminis-
ration of the glucocorticoid agonist triamcinolone to ferret lingual
erve at the time of injury reduces injury-enhanced, evoked elec-
rical activity in the nerve as long as 3 months after the injury
27].
It is likely that dexamethasone exerts its antihyperalgesic and
ntiallodynic effects through multiple mechanisms. The proinﬂam-
atory responses of neutrophils, macrophages, lymphocytes and
ast cells, which normally inﬁltrate into the nerve after injury
14,15], can be suppressed by dexamethasone [3,5,10,11,26]. More-
ver, Schwann cells are activated after CCI [6], and their production
f cytokines and chemokines is inhibited by dexamethasone in vitro
17], though in vivo evidence seems to be lacking. These various
ell types can release a wide array of inﬂammatory mediators
hich sensitize or activate nociceptive neurons, thereby enhancing
ain [4]. Given the pleiotropic genomic and non-genomic anti-
nﬂammatory actions of dexamethasone [1], it may  prevent the
nitial proinﬂammatory events initiated in response to CCI and thus
revent or delay the subsequent development of hyperalgesia or
llodynia.
Besides actions on immune cells, both genomic and non-
enomic actions on neurons may  be hypothesized to explain the
ffect induced by intraneural dexamethasone on the development
f hyperalgesia and allodynia. Supporting genomic actions, modu-
ation of expression of channels involved in excitability of neurons
n nociceptive pathways by glucocorticoids may  also interfere with
ociceptive responses [22]. Dexamethasone may  alter expression
f pain-relevant receptors, as prenatal exposure of rats to dexam-
thasone decreases P2X3 expression in DRG and spinal cord [22],
hough effect on P2X3 expression in adult rats remains to be tested.
urthermore, glucocorticoids can alter the expression of neuro-
ransmitters implicated in pain transmission. For example, removal
f endogenous glucocorticoids by adrenalectomy increases calci-
onin gene-related peptide (CGRP) concentrations in the dorsal root
anglia (DRG) suggestive that increases in glucocorticoids may  be
ble to suppress CGRP production. As the adrenalectomy-induced
ncreases in CGRP were reversed by dexamethasone [19], this give
redence to the idea that glucocorticoids, rather than other adrenal
actors, underlie the effects observed.
In conclusion, the results reinforce the evidence that early neu-
oimmune interactions are essential for triggering mechanisms
ecessary for the development of long lasting thermal hyperal-
esia and mechanical allodynia in models of neuropathic pain,
hough additional actions on neural excitability may  also be
aken into account. The study presents a localized methodological
pproach that opens opportunities to study in detail the cellular and
olecular multi-step inﬂammatory processes by which peripheral
europathies lead to persistent, pathological pain states.
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